Bausch Health Companies Inc. (TSE:BHC - Get Free Report) traded down 0.7% on Friday . The stock traded as low as C$7.38 and last traded at C$7.53. Approximately 289,086 shares were traded during trading, a decline of 14% from the average session volume of 336,120 shares. The stock had previously closed at C$7.58.
Bausch Health Companies Stock Performance
The firm has a 50 day moving average of C$8.72 and a two-hundred day moving average of C$10.30. The company has a debt-to-equity ratio of -1,831.94, a current ratio of 1.19 and a quick ratio of 0.58. The stock has a market cap of C$1.90 billion, a PE ratio of -10.70, a PEG ratio of 0.21 and a beta of 0.77.
About Bausch Health Companies
(
Get Free Report)
Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.
See Also
Before you consider Bausch Health Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bausch Health Companies wasn't on the list.
While Bausch Health Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
